当前位置: 首页 >> 检索结果
1. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center's results].
作者: E N Parovichnikova.;V V Troitskaia.;G A Kliasova.;L A Kuz'mina.;A N Sokolov.;E V Paramonova.;G M Galstian.;S A Kessel'man.;M Iu Drokov.;V A Vasil'eva.;T N Obukhova.;S M Kulikov.;V G Savchenko.
来源: Ter Arkh. 2014年86卷7期14-23页
To make a randomized comparison of 2 consolidation treatment options (two patient groups): 2 cycles of cytarabine in average (Ig/m2 in Group 2) and standard (100 mg/mi2 in Group 1) doses in combination with idarubicin (8-12 mg/m2) and mitoxantrone (10 mg/m2), after two 7+3 induction cycles of daunorubicin (60 mg/mi2) and subsequent 6 cycles of maintenance therapy.
2. [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
作者: E N Parovichnikova.;V G Savchenko.;I A Demidova.;V G Isaev.;E N Shuravina.;E N Ustinova.;E O Gribanova.;M Zh Aleksanian.;A V Misiurin.;E V Domracheva.;Iu V Ol'shanskaia.;N D Khoroshko.;S K Kravchenko.;T S Konstantinova.;L V Anchukova.;K Kaplanov.;T P Zagoskina.;S A Volkova.;L B Filatov.;G B Rekhtman.;I Sokolova.;V N Mashuk.;G I Miliutina.;V A Lapin.;T N Perekatova.;E I Sviridova.;A S Pristupa.;I S Ziuzgin.
来源: Ter Arkh. 2004年76卷7期11-8页
To study efficacy of maintenance therapy of patients with acute promyelocytic leukemia (APL) in the APL treatment Russian multicenter trial.
3. [Molecular-genetic determinants of the neoplastic process and state-of-the-art treatment of patients with uterine leiomyoma].
Present-day evidence on uterine leiomyomata has pointed to progesterone and its receptors as a key factor in the mechanisms of auto- and paracrine influences on tumor development and growth. Treatment was determined by a correlation between tumor size and stage of molecular-genetical disorders. A clinico-genealogical study of familial predisposition to uterine leiomyoma, particularly in patients from accumulated disease families contributed to the potential of early detection of tumor and timely effective correction for preservation of reproductive function.
4. [Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)].
作者: N D Khoroshko.;A G Turkina.;A V Zakharova.;Iu N Kobzev.;E V Domracheva.;L Iu Tikhonova.;E A Semenova.;V S Zhuravlev.;M A Sokolova.;S V Kuznetsov.
来源: Ter Arkh. 1999年71卷7期42-7页
Evaluation of clinical effectiveness of two regimens of induction therapy of an early chronic stage of Ph'-positive chronic myeloid leukemia including interferon-alpha 2b (intron-A, "Schering Plough") in a cooperative randomised trial on the protocol CML MIG-97.
|